Our study highlights several genes in the EGFR and TGF-β signaling pathways as key constituents of the p63-gene signature that can stratify tumors from normal tissues in an independent cohort of HNSCC patients. The gene discussed is TGFB1; the disease is head and neck squamous cell carcinoma.